MIR3154

Across TCGA pan-cancer cohorts, MIR3154 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR3154 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher MIR3154 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3154 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

TGCT, UVM, and THYM are the cancer types where MIR3154 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	108	view →
UVM	OS	Tertile	All	0.136	0.919	<.001	90	view →
THYM	OS	Tertile	All	0.068	0.977	<.001	72	view →
MESO	DFS	Tertile	III,IV	0.060	0.423	<.001	72	view →
STAD	OS	Tertile	IV	0.162	0.518	.017	36	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	27	view →
KIRC	OS	Tertile	II,III,IV	0.627	0.793	.036	24	view →
LAML	DFS	Tertile	All	0.704	0.521	.034	22	view →
PAAD	OS	Tertile	II,III,IV	0.307	0.563	.006	18	view →
COAD	DFS	Tertile	II,III,IV	0.135	0.747	<.001	18	view →
BRCA	DFS	Tertile	III,IV	0.246	0.799	<.001	18	view →
SKCM	OS	Tertile	All	0.333	0.780	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR3154–TGCT (OS)

Open the TGCT breakdown →